Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that the genetic variants rs231775 and rs3087243 of the CTLA4 gene are not associated with alopecia areata in the Mexican population analyzed.

This study found that severe forms of alopecia areata may be associated with poor treatment response, particularly in cases with extensive hair loss, juvenile onset, or nail changes.

In this study conducted at a tertiary care hospital in Karachi, oral Apremilast significantly reduced the severity of alopecia areata, shown by a notable decrease in SALT Scores over 12 weeks, suggesting it may be an effective alternative treatment option for this condition.

CCCA in African Americans may be linked to hair grooming, low vitamin D, and autoimmune factors.

This paper discusses the role of the National Alopecia Areata Foundation in advancing research on alopecia areata, emphasizing genetic and immunological factors, and reports no new clinical findings.

This review discusses potential roles of zinc and copper in hair loss conditions like AA and TE, hypothesizing zinc's key role but noting that copper's effects need further investigation; it reports no new clinical findings.

This study found that type A botulinum toxin treatment significantly increased hair thickness and reduced vellous hair count in patients with androgenetic alopecia, suggesting its potential as an effective therapy.

A new microneedle patch effectively and safely treats alopecia areata.

In this study, oral dutasteride treatment for at least 12 months was associated with either stabilization or improvement of male-pattern hair loss in the majority of patients.

This study examined the current prescribing patterns of Australian dermatologists in treating androgenetic alopecia in men, highlighting the limited treatment options available despite the condition's prevalence and psychological impact.

In this review, the article explores the role of homeopathy, as supported by the AYUSH ministry, in addressing Alopecia Areata, discussing its global and national prevalence, existing challenges, and recommending a treatment protocol for future programmatic integration.

Apremilast may help treat hair loss in alopecia areata.

This study found that 308 nm excimer lamp therapy provides a good clinical response with fewer adverse effects for limited alopecia areata but is less effective for widespread hair loss like alopecia totalis.

This study evaluated online resources for alopecia areata patients and highlighted the value of directing them to Alopecia UK, National Alopecia Areata Foundation, and Health Talk for psychological support.

In this case report, a nearly 12-year-old boy with alopecia universalis and atopic dermatitis experienced full hair regrowth and improved dermatitis following treatment with upadacitinib, a JAK 1 inhibitor, showing notable positive effects on his psychological well-being and family.

In this study, women with androgenetic alopecia underwent stem cell treatment, which led to significant improvements in sexual arousal and satisfaction, psychological health, and environmental quality of life, but not in physical health or social relationships after six months.

In this study, machine learning-based computer-aided diagnosis significantly improved accuracy in diagnosing alopecia areata compared to traditional visual methods, achieving up to 91.9% accuracy using different classifiers like CNN, SVM, and random forest models.

This study observed a high prevalence of severe markers among pediatric alopecia areata patients, identifying AA subtotalis as more frequent, with nail changes and various hair markers suggesting progression to severe forms.

Automated image analysis helps diagnose and monitor alopecia areata by efficiently measuring hair follicles.

This study reported that patients with alopecia areata experienced significant increases in work productivity loss and activity impairment due to worsening emotional symptoms, highlighting a need for better treatments.

In this case report, upadacitinib was used to treat a 21-year-old female with severe alopecia areata, resulting in significant hair regrowth; however, rapid hair loss recurred soon after discontinuing the drug, illustrating its potential efficacy as well as the risk of relapse upon stopping treatment.

This study identified four genetic loci on chromosomes 6, 10, 16, and 18 that may contribute to susceptibility for alopecia areata and suggested shared genetic factors with psoriasis.

This study identified changes in immune activation, ferroptosis, and structural genes in alopecia areata subtypes, suggesting molecular markers that might help understand disease variability and guide future treatments.

This study found that 5-aminolevulinic acid significantly improved chicken sperm motility and increased mitochondrial membrane depolarization, while decreasing ATP levels.

This study evaluated azathioprine in treating alopecia areata and found that it was effective for 77.4% of patients, significantly reducing SALT scores after 6 months of treatment, with safety monitored through regular testing.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

This study observed that men with vertex androgenetic alopecia at age 40 had a higher risk of early-onset prostate cancer, suggesting a potential link between the conditions.

This article outlines treatment options and counseling recommendations for pediatric alopecia areata, highlighting shared decision-making based on disease severity and patient goals, with newer treatments like JAK inhibitors and dupilumab requiring attention to cost and side effects.

This pilot study found that Optical Coherence Tomography can non-invasively resolve hair follicle density and hair shaft and follicle diameters in patients at varying stages of hair loss.